Inflammatory and immune myopathies, not elsewhere classified Save
ICD-10 code: G72.4
Chapter: Diseases of the nervous system
Inflammatory and immune myopathies, not elsewhere classified
Inflammatory and immune myopathies are a group of rare autoimmune diseases that affect the muscles and cause weakness. These diseases occur when the body's immune system attacks its own muscles, leading to inflammation and damage. There are several types of inflammatory and immune myopathies, including polymyositis, dermatomyositis, inclusion body myositis, and necrotizing autoimmune myopathy. However, there are also cases in which the disease cannot be classified as any of these types, and is referred to as "inflammatory and immune myopathies, not elsewhere classified."
The symptoms of these myopathies can vary, but typically include muscle weakness, difficulty standing or walking, fatigue, and pain. In some cases, there may also be skin rashes or other signs of inflammation. These symptoms can be gradual and progressive, making it difficult for patients to perform daily activities.
Diagnosis of inflammatory and immune myopathies, not elsewhere classified, can be challenging, and may require a combination of clinical assessment, laboratory tests, and muscle biopsies. Treatment usually involves immunosuppressive drugs, such as corticosteroids, and sometimes other medications such as methotrexate or azathioprine. Physical therapy and rehabilitation may also be helpful in improving muscle strength and function.
- Polymyositis
- Dermatomyositis
- Inclusion body myositis
- Necrotizing autoimmune myopathy
If you suspect you may have an inflammatory or immune myopathy, it is important to seek medical attention promptly. These conditions can be serious and may lead to permanent muscle damage if left untreated. With proper diagnosis and treatment, however, many patients are able to manage their symptoms and maintain a good quality of life.
Overall, inflammatory and immune myopathies, not elsewhere classified, are a group of rare diseases that can cause significant muscle weakness and disability. While diagnosis and treatment can be challenging, early intervention can help to improve outcomes and prevent long-term damage.